Work Here?
Calibrate
Work Here?
Subscription-based health-tech for metabolic weight loss
Calibrate
Work Here?
Subscription-based health-tech for metabolic weight loss
About Calibrate
Industries
Consumer Software
Enterprise Software
Biotechnology
Healthcare
Company Size
201-500
Company Stage
Growth Equity (Venture Capital)
Total Funding
$156.6M
Headquarters
New York City, New York
Founded
2020
Overview
Calibrate focuses on sustainable weight loss by improving metabolic health rather than traditional dieting. It delivers a subscription-based program, commonly covered by employers, combining incremental habit changes with GLP-1 medication that targets biology to reduce inflammation, regulate digestion, enhance metabolic function, and lower cardiovascular risk. The program reports real-world results of about 15% sustained weight loss, distinguishing it from typical clinical trial claims. Clients are primarily corporations seeking employee wellness benefits, though individuals can subscribe too. The company offers a money-back guarantee if promised results aren’t achieved. Overall, Calibrate aims to help people lose weight and improve metabolic health in a practical, maintainable way, scaling through employer-based wellness programs.
Simplify's Take
What believers are saying
- Doubled client base nearing profitability in enterprise shift.
- Rob MacNaughton leads scaling with OptumRx partnerships.
- 19% weight loss over three years validated in real-world data.
What critics are saying
- Noom undercuts with cheaper enterprise GLP-1 coaching.
- Madryn enforces cost cuts causing clinician exodus.
- FDA enforcement disrupts compounded GLP-1 access via warnings.
What makes Calibrate unique
- Calibrate achieves 15% sustained weight loss outside clinical trials.
- Enterprise model covers 90% revenue via employer wellness programs.
- Combines GLP-1s with coaching for metabolic health beyond dieting.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$156.6M
Above
Industry Average
Funded Over
4 Rounds
Tiger Global
Founders FundBenefits
Competitive salary with opportunity for equity in an early stage, high growth business
Generous paid time off, including an all-company holiday over Thanksgiving week
Calibrate-funded health benefits (medical, dental, vision) - starting at zero cost to you
One Medical membership and Teladoc virtual care
Fertility, gynecology, and wellness services through Kindbody
Therapy on your time with a free year of Talkspace membership
Health advocacy and assistance services through Health Advocate
Commuter benefits, ClassPass memberships, and gym memberships for post-pandemic life
Remote team with a headquarters in NYC
Competitive Paid Parental Leave for parents
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↓ -1%Calibrate, a digital obesity management platform, has completed its transition from direct-to-consumer to an enterprise-focused model, more than doubling its client base over the past year. The shift positions the company to achieve profitability for the first time in its history. The move responds to growing employer demand for weight management solutions as organisations grapple with rising costs and sustainability concerns around GLP-1 medications. Enterprise adoption now represents approximately 90% of Calibrate's business, with clients ranging from several thousand to several hundred thousand covered lives. Since launching over five years ago, more than 100,000 members have used Calibrate's integrated clinical care and coaching platform. The company has assembled a new leadership team to support its next growth phase, including CEO Rob Rebak and executives across operations, medical, commercial and finance functions.
Calibrate secures $100M in series B funding to revolutionize weight treatment.
Rob MacNaughhton, CEO at CalibrateWhat You Should Know:– Calibrate, the leading clinician-guided and value-based obesity treatment program, today announced the appointment of Rob MacNaughton as its new Chief Executive Officer.– Calibrate’s strategic direction under MacNaughton’s leadership and the OptumRx partnership position the company for significant growth and a positive impact on both individual and corporate healthcare landscapes.MacNaughton Bio/BackgroundMacNaughton boasts a distinguished track record in launching new healthcare ventures, overseeing product development, and scaling operations. Prior to Calibrate, MacNaughton served as Venture Chair at Redesign Health, overseeing the launch and growth of several healthcare delivery and technology brands. His previous roles include CEO positions at Curve Health and Nurse Grid, and Chief Product Officer at Cambia Health Solutions, a multi-state Blue Cross Blue Shield payor.“Obesity is the largest category of chronic disease and one of the biggest drivers of healthcare spending. I’m honored to join a company at the forefront of value-based obesity care and a business that is clearly committed to addressing the epidemic head on while helping employers and insurers manage soaring costs,” said Calibrate CEO, Rob MacNaughton. “Our commercial momentum is stronger than ever, and we are confident we will continue to collaborate with industry leaders to deliver best-in-class sustained outcomes.”
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Calibrate, the weight loss startup that rose in popularity with the rise of GLP-1 medications only to struggle to get patients access to those medications — leading to patient complaints and refunds
Weight loss startup Calibrate raises $29M as part of private equity restructuring.
There are no jobs for Calibrate right now.
Find jobs on Simplify and start your career today
About Calibrate
Industries
Consumer Software
Enterprise Software
Biotechnology
Healthcare
Company Size
201-500
Company Stage
Growth Equity (Venture Capital)
Total Funding
$156.6M
Headquarters
New York City, New York
Founded
2020
There are no jobs for Calibrate right now.
Find jobs on Simplify and start your career today